INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2014
|
Net Assets |
£218m |
|
Net Assets per share |
402p |
|
Share price |
321p |
|
Total value of unquoted investments |
£19m |
|
Total number of portfolio companies |
90 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
8.1 |
|
Regeneron |
6.9 |
|
Celgene |
6.9 |
|
Biogen-Idec |
5.0 |
|
Alexion |
4.7 |
|
Amgen |
4.2 |
|
Illumina |
3.6 |
|
Chimerix |
3.3 |
|
Actelion |
2.9 |
|
Biomarin |
2.9 |
|
|
----------- |
|
Total |
48.5 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
62 |
|
Turning Profitable 2015 |
6 |
|
Unprofitable |
32 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
87 |
|
Europe & UK |
13 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
92 |
|
Unquoted |
8 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
30 OCTOBER 2014